Indoco Remedies Fixes Record Date for Final Dividend and AGM on September 10, 2026
Indoco Remedies Limited has set September 10, 2026, as the record date for its final dividend of ₹0.20 per equity share and for e-voting for the AGM. The book closure is from September 11 to September 17, 2026. The AGM is scheduled for September 17, 2026.
This is a standard procedural announcement related to dividend payment and AGM, which is a routine event for listed companies and has a low impact on the company's operations or stock price.
The announcement is a routine corporate action regarding dividend payment and AGM procedures, with no significant positive or negative financial implications mentioned.
Indoco Remedies Limited has announced the cut-off date for e-voting, book closure, and the record date for its final dividend and Annual General Meeting (AGM). The company has fixed Thursday, September 10, 2026, as the Record Date for determining shareholder entitlements to the final dividend for the financial year ended March 31, 2026. This dividend was recommended by the Board of Directors at their meeting on May 7, 2026, and is subject to shareholder approval at the AGM.
The Register of Members and Share Transfer Books will be closed from Friday, September 11, 2026, to Thursday, September 17, 2026, inclusive. This period is for recording members for the purpose of final dividend payment and the AGM.
Furthermore, September 10, 2026, has been set as the cut-off date for remote e-voting and e-voting during the AGM. This will determine the shareholders eligible to cast their votes electronically regarding the businesses to be transacted at the AGM. If approved, the final dividend will be paid within 30 days, subject to tax deductions at source.
What to do with a filing like this
Indoco Remedies Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indoco Remedies Limited. Read the original for the full detail.